title: Administrative drug submissions to be excluded from the PM(NOC) regulations?
authors.affiliation: Intellectual Property Group, Fasken Martineau DuMoulin LLP, Canada.
authors.forename: Richard Y
authors.initials: RY
authors.lastname: Cheung
mesh_terms: D002170:Canada; D006801:Humans; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*